✦ LIBER ✦

5-Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy

✍ Scribed by Ivanoff, Sarah; Gruson, Berengere; Chantepie, Sylvain P.; Lemasle, Emilie; Merlusca, Lavinia; Harrivel, Veronique; Charbonnier, Amandine; Votte, Patrick; Royer, Bruno; Marolleau, Jean-Pierre

Book ID: 127037681
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 135 KB
Volume: 88
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.23464

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Salvage therapy for relapsed or refracto

Salvage therapy for relapsed or refractory acute myeloid leukemia

✍ Mangan, J. K.; Luger, S. M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 141 KB

Treatment of Relapsed Acute Myeloid Leuk

Treatment of Relapsed Acute Myeloid Leukemia Using GM-CSF Before Intensive Chemotherapy

✍ Puntous, M.; Marit, G.; Boiron, J. M.; Cony-Makhoul, P.; Reiffers, J.; Dumain, P 📂 Article 📅 1993 🏛 Informa plc 🌐 English ⚖ 689 KB

5-Azacytidine for the treatment of patie

5-Azacytidine for the treatment of patients with acute myeloid leukemia or myelodysplastic syndrome who relapse after allo-SCT: a retrospective analysis

✍ Czibere, A; Bruns, I; Kröger, N; Platzbecker, U; Lind, J; Zohren, F; Fenk, R; Ge 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 253 KB

Sorafenib as treatment for relapsed or r

Sorafenib as treatment for relapsed or refractory pediatric acute myelogenous leukemia

✍ Tanya C. Watt; Todd Cooper 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

Late-phase investigational approaches fo

Late-phase investigational approaches for the treatment of relapsed/refractory acute myeloid leukemia

✍ Jamieson, Katarzyna; Odenike, Olatoyosi 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 322 KB

Induction of complete remission in a pat

Induction of complete remission in a patient with acute myeloid leukemia refractory to high-dose chemotherapy through treatment with 5-azacytidine

✍ A. Kuendgen; T. Gräf; F. Zohren; B. Hildebrandt; A. Hünerlitürkoglu; N. Gatterma 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 654 KB

For patients with acute myeloid leukemia refractory to intensive chemotherapy prognosis is very poor and treatment options are limited. 5-Azacytidine, a demethylating drug, is effective in the treatment of myelodysplastic syndromes when administered at a low-dose, subcutaneously. We report a case of